Nasdaq Futures Tumble, Stocks Slide As SoftBank Unwinds, Dollar Jumps
Sanofi's Covid-19 Vaccine Could Cost Under €10 Per Shot, Says Senior Exec
The new UK Climate and Ecological Emergency Bill is exactly what we need – here's why
"The Correction Has Further Room To Go": Futures Recover Early Losses As European Markets Jump
France Again Being Forced To Stimulate Is Bad News
COVID-19 patients suffer long-term lung and heart damage but it can improve with time
"Bipartisan" Washington Insiders Reveal Their Plan For Chaos If Trump Wins The Election
Payday loans: clampdown was vital, but credit unions must expand after coronavirus to fill gap
Week Ahead – Trump Closing the Gap
Unconventional T cells in severe COVID-19 patients could predict disease outcome
Coronavirus: what researchers know about the risk of reopening schools – and how best to limit it
Labor Day celebrates earning a living, but remember what work really means
One Bank Warns The Coming Flu Season Could Lead To Chaos
Has the FTSE 100 really performed as badly this century as it appears?
Equity market: Summer party
Too Little is not Enough
SSGA launches global value ETF
Remote-work visas will shape the future of work, travel and citizenship
A sea-change for pharma? Pandemic commercial models and launch
US Open – Wall Street Flat After Broad Surge
S&P Futures Inexplicably Dip As "Magical, Non-Stop Rally" Reverses
Corrective Forces Maintain Grip
Sanofi, GSK launch trial for Covid-19 protein-based vaccine
Highway To Hell
EU Official Warns COVID-19 Cases "Almost Back To March Levels": Live Updates
Former Italian PM Silvio Berlusconi Tests Positive For COVID-19; France Suffers Another Alarming Jump: Live Updates
Where in the world is the FinTech revolution taking place?
Steroids cut death rates among critically ill Covid-19 patients, major study finds
Sanofi Says Kevzara Drug Fails To Meet Endpoints in Covid-19 Study
News briefing: Novartis hands off NASH drug to biotech collaborator, also plans to build new Basel production unit